secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0000950170-24-080497
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Atossa appoints Heather Rees as CFO, increases authorized shares to 360M
------------------------------------------------------------------------

- Heather Rees appointed CFO effective June 27, 2024; salary set at $439,700 with 40% bonus target.
- Rees granted 577,700 stock options vesting quarterly over two years under the 2020 Plan.
- Stockholders approved increase in authorized common shares from 175M to 350M (total authorized to 360M).
- Amendment and restatement of 2020 Stock Incentive Plan approved, adding 12M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/0000950170-24-080497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/atos-20240627.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-080497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer